Frontage Holdings Corporation (FGHQF)
OTCMKTS
· Delayed Price · Currency is USD
0.1010
-0.0190 (-15.83%)
At close: Jun 21, 2024
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Laboratory Testing | 968.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Testing Growth | 32.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Development | 744.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Discovery | 261.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Product Development | 59.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Preclinical Research | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Preclinical Research Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemistry, Manufacturing and Controls | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemistry, Manufacturing and Controls Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemistry | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemistry Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Early Stage Clinical/Bioequivalence | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Early Stage Clinical/Bioequivalence Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Metabolism and Pharmacokinetics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Metabolism and Pharmacokinetics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Safety and Toxicology | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Safety and Toxicology Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| North America | 1.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 1.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 475.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 12.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|